[Drug-induced and masked drug parkinsonism].
Giménez-Roldán
S
S
Mateo
D
D
Dobato
J L
JL
D000368:Aged; D000873:Anthracenes / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D000929:Antidepressive Agents, Tricyclic / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D003866:Depressive Disorder / Q000188:drug therapy; D004338:Drug Combinations; D005260:Female; D005475:Flupenthixol / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D010302:Parkinson Disease, Secondary / Q000209:etiology*
D000873:Anthracenes; D000929:Antidepressive Agents, Tricyclic; D004338:Drug Combinations; C005100:melitracene; D005475:Flupenthixol
Parkinsonismo inducido por fámacos y medicamentos enmascarados.